Advanced search
Publication Cover
Acute Cardiac Care Volume 15, 2013 - Issue 4
Journal homepage
178
Views
12
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Heart-type fatty acid-binding protein may exclude acute myocardial infarction on admission to emergency department for chest pain

Fabrizio CappelliniDepartment of Laboratory Medicine, University Milano-Bicocca, Desio Hospital, Desio (MB), ItalyCorrespondence[email protected]
,
Simona Da MolinDepartment of Laboratory Medicine, University Milano-Bicocca, Vimercate Hospital, Vimercate (MB), Italy
,
Stefano SignoriniDepartment of Laboratory Medicine, University Milano-Bicocca, Desio Hospital, Desio (MB), Italy
,
Fausto AvanziniDepartment of Cardiology, Desio Hospital, Desio (MB), Italy
,
Donata SaltafossiDepartment of Cardiology, Desio Hospital, Desio (MB), Italy
,
Rosanna FalboDepartment of Laboratory Medicine, University Milano-Bicocca, Desio Hospital, Desio (MB), Italy
&
Paolo BrambillaDepartment of Laboratory Medicine, University Milano-Bicocca, Desio Hospital, Desio (MB), Italy;Department of Experimental Medicine, School of Medicine, University Milano-Bicocca, Milano, Italy
 show all
Pages 83-87 | Received 06 Nov 2012, Accepted 03 Sep 2013, Published online: 06 Nov 2013

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jan Fc Glatz & Reinhard Renneberg. (2014) Added value of H-FABP as a plasma biomarker for the early evaluation of suspected acute coronary syndrome. Clinical Lipidology 9:2, pages 205-220.
Read now

Articles from other publishers (11)

Farah Omran, Ioannis Kyrou, Faizel Osman, Ven Gee Lim, Harpal Singh Randeva & Kamaljit Chatha. (2022) Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future. International Journal of Molecular Sciences 23:10, pages 5680.
Crossref
Giulia Bivona, Luisa Agnello, Chiara Bellia, Bruna Lo Sasso & Marcello Ciaccio. (2018) Diagnostic and prognostic value of H-FABP in acute coronary syndrome: Still evidence to bring. Clinical Biochemistry 58, pages 1-4.
Crossref
Andreas W Schoenenberger, Fabio Stallone, Brigitte Walz, Michael Bergner, Raphael Twerenbold, Tobias Reichlin, Bernhard Zogg, Cedric Jaeger, Paul Erne & Christian Mueller. (2015) Incremental value of heart-type fatty acid-binding protein in suspected acute myocardial infarction early after symptom onset. European Heart Journal: Acute Cardiovascular Care 5:2, pages 185-192.
Crossref
Robert T. A. Willemsen, Geert Jan Dinant & Jan F. C. Glatz. 2016. Biomarkers in Cardiovascular Disease. Biomarkers in Cardiovascular Disease 235 265 .
Suna Aydin & Suleyman Aydin. 2016. Biomarkers in Cardiovascular Disease. Biomarkers in Cardiovascular Disease 489 504 .
Kevin Liou, Suyen Ho & Sze-Yuan Ooi. (2014) Heart-type fatty acid binding protein in early diagnosis of myocardial infarction in the era of high-sensitivity troponin: a systematic review and meta-analysis. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 52:3, pages 370-381.
Crossref
Yu-ping Sun, Chao-ping Wei, Shao-chun Ma, Yuan-feng Zhang, Ling-yan Qiao, De-hua Li & Ruo-bing Shan. (2015) Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure. Journal of Cardiovascular Pharmacology 65:5, pages 480-484.
Crossref
Sebastian Johannes Reinstadler, Gert Klug, Hans-Josef Feistritzer, Bernhard Metzler & Johannes Mair. (2015) Copeptin Testing in Acute Myocardial Infarction: Ready for Routine Use?. Disease Markers 2015, pages 1-9.
Crossref
Robert T. A. Willemsen, Geert Jan Dinant & Jan F. C. Glatz. 2015. Biomarkers in Cardiovascular Disease. Biomarkers in Cardiovascular Disease 1 31 .
Suna Aydin & Suleyman Aydin. 2015. Biomarkers in Cardiovascular Disease. Biomarkers in Cardiovascular Disease 1 16 .
Simona Da Molin, Fabrizio Cappellini, Rosanna Falbo, Stefano Signorini & Paolo Brambilla. (2014) Verification of an immunoturbidimetric assay for heart-type fatty acid-binding protein (H-FABP) on a clinical chemistry platform and establishment of the upper reference limit. Clinical Biochemistry 47:16-17, pages 247-249.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.